Olivier Tournilhac, Magali Le Garff-Tavernier, Stéphanie Nguyen Quoc, Edouard Forcade, Patrice Chevallier, Faezeh Legrand-Izadifar, Gandhi Laurent Damaj, David Michonneau, Cécile Tomowiak, Cécile Borel, Corentin Orvain, Pascal Turlure, Rabah Redjou, Gaëlle Guillerm, Laure Vincent, Celestine Simand, Richard Lemal, Claire Quiney, Patricia Combes, Bruno Pereira, Laure Calvet, Aurélie Cabrespine, Jacques-Olivier Bay, Véronique Leblond, Nathalie Dhédin, French Innovative Leukemia Organization (FILO), and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). 2020. “Efficacy of Minimal Residual Disease Driven Immune-Intervention After Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Chronic Lymphocytic Leukemia: Results of a Prospective Multicenter Trial”. Haematologica 106 (7). Pavia, Italy, 1867-75. https://doi.org/10.3324/haematol.2019.239566.